• Citer

Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experience.

par Gulbis, Béatrice ;Haberman, David;Dufour, Dominique ;Christophe, Catherine ;Vermylen, C;Kagambega, Faustin;Corazza, Francis ;Devalck, Christine ;Dresse, Marie-Françoise;Hunninck, Kathleen;Klein, Axel;Lê, Phu Quoc ;Loop, Michèle ;Maes, Philip;Philippet, Pierre;Sariban, Eric ;Van Geet, Chris;Ferster, Alina
Référence Blood, 105, 7, page (2685-2690)
Publication Publié, 2005-04

Article révisé par les pairs

• Détails
• Contenu

Titre:	Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experience.
Auteur:	Gulbis, Béatrice; Haberman, David; Dufour, Dominique; Christophe, Catherine; Vermylen, C; Kagambega, Faustin; Corazza, Francis; Devalck, Christine; Dresse, Marie-Françoise; Hunninck, Kathleen; Klein, Axel; Lê, Phu Quoc; Loop, Michèle; Maes, Philip; Philippet, Pierre; Sariban, Eric; Van Geet, Chris; Ferster, Alina
Informations sur la publication:	Blood, 105, 7, page (2685-2690)
Statut de publication:	Publié, 2005-04
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adolescent
	Adult
	Anemia, Sickle Cell -- drug therapy
	Anemia, Sickle Cell -- epidemiology
	Antisickling Agents -- administration & dosage
	Antisickling Agents -- adverse effects
	Belgium -- epidemiology
	Child
	Child, Preschool
	Female
	Follow-Up Studies
	Humans
	Hydroxyurea -- administration & dosage
	Hydroxyurea -- adverse effects
	Infant
	Male
	Patient Compliance
	Recurrence -- prevention & control
	Registries
	Risk Factors
	Stroke -- epidemiology
	Stroke -- prevention & control
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0006-4971
	info:doi/10.1182/blood-2004-07-2704
	info:pii/2004-07-2704
	info:scp/20144386780
	info:pmid/15604217